News
Earth's Best, Once Upon a Farm, and Plum Organics earned top scoresA new California law helps consumers figure out whether ...
Travere Therapeutics has successfully executed a significant restructuring to recover from previous setbacks and improve its ...
1d
Zacks.com on MSNCan Eli Lilly Keep Up as NVO Eyes First Oral Obesity Pill Approval?
The two main players in the global obesity market are Eli Lilly LLY and Novo Nordisk NVO, with their respective GLP-1 ...
NEW YORK, Aug. 11, 2025) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully hum ...
Hims & Hers Health is upgraded to a speculative Buy after a 20% drop, with growth potential in GLP-1 sales outweighing key ...
Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results